RUBIN PAUL D sold BIOA
April 1, 2026 · Form 4 insider transaction
RUBIN PAUL D sold 8,820 shares of BioAge Labs, Inc. at $17.81 per share, a transaction worth $157.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,820
Price
$17.81
Total value
$157.1K
InsiderRUBIN PAUL D
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.